Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Banlangen Chongji + modified Yin Qiao San for acute upper respiratory tract infection
ChiCTR-TRC-10000906Phase 4Completed
- Sponsor
- West China Hospital of Sichuan University
- Start
- Apr 2010
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of ban lan gen and modified Yin Qiao San in upper respiratory infection (URI) (4 arms), sponsored by West China Hospital of Sichuan University. Primary endpoints: Inefficiency and complication rate and Cure rate. Started Apr 2010; status: completed.
02
Drugs
ban lan genmodified Yin Qiao San
03
Conditions
upper respiratory infection (URI)
Beyond the preview
Go deeper on ChiCTR-TRC-10000906.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-10000906.